Finland· FI-REL-REL1775

Selevitan vet.

A seleeni, yhdistelmävalmisteet product containing alpha-tocopherol acetate + sodium selenite, registered in Finland by Pharmaxim AB.

ATC QA12CE99

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSelevitan vet.ATCQA12CE99REGISTER NO.FI-REL-REL1775PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Alpha-tocopherol acetate + Sodium selenite
Manufacturer
Pharmaxim AB
Country
Finland (FI)
ATC code
QA12CE99
ATC class
Seleeni, yhdistelmävalmisteet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/22d88ba1-1c1e-4150-8708-7527079c37c4
GET /v1/drugs/22d88ba1-1c1e-4150-8708-7527079c37c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": "Lihakseen",
  "ddd_unit": null,
  "strength": "50 mg/ml + 0.6 mg/ml",
  "atc_label": "Seleeni, yhdistelmävalmisteet",
  "ma_number": "8865",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1775",
  "authorised_at": "1984-10-10"
}

See everything about alpha-tocopherol acetate + sodium selenite.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.